multivalent peptide vaccine (ProMIS Neurosciences)

N/A

Report date: 2025/01/26 16:26:38

Base Information

Drug Namemultivalent peptide vaccine (ProMIS Neurosciences)

Drug Alias Nameamyloid-beta toxic oligomers antigonist (ProMIS Neurosciences)amyloid-beta toxic oligomers antigonist (ProMIS Neurosciences)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionBeta amyloid A4 protein inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProMIS Neurosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A